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SUMMARY 
Serum obtained from mice 3 to 5 weeks after the third i.p. dose of dengue type 
2 virus (DV) protected recipient mice against intracerebral challenge with DV, 
whereas the serum obtained after I and 2 weeks provided minimum protection. 
Adoptive intravenous transfer of immune spleen cells obtained from mice I to 5 
weeks after immunization did not protect recipient mice against even a small dose 
(IO LDs0 ) of DV. Depletion of T-cells by treatment ofmice with anti-thymocyte 
serum did not potentiate DV infection. Development of a cell-mediated immune 
response (CMI) against DV was noted only at two periods by the leucocyte migra- 
tion inhibition test (LMI), with borderline values of 20 and 21%. Dengue virus 
did not cause illness or death in mice when given by i.p. or i.v. routes and this was 
not affected by pre-treatment of mice with silica to damage local macrophages. It is 
concluded that humoral antibody plays a critical role in recovery from primary 
dengue virus infection of mice whereas CMI and macrophages appear to have no 
protective role. 
INTRODUCTION 
Dengue virus infection in humans may be associated with haemorrhagic manifestations 
(Rao & Anderson, I964; Halstead, 1966; Chaturvedi et al. ~97oa, b). There is a possibility 
that immunopathological processes determine whether infection with dengue virus results 
in a benign or a haemorrhagic fever (Halstead, I966; Hammon, 1966), although our findings 
on three epidemics of dengue do not support his view (Kapoor et al. 1978). 
Immune mechanisms play an important role in recovery from virus infections. Humoral 
antibody and cell-mediated immunity (CMI) may both be active, but in a number of virus 
infections the role of CMI is considered to be more important (Allison, 1972). A contribu- 
tory factor in the development of resistance against herpes implex, yellow fever and Cox- 
sackie B3 virus infection is the macrophage (Hirsch et al. I97o; Zisman et al. I97I ; Rager- 
Zisman & Allison, 1973). Halstead et al. (1973) have reported peripheral blood lymphocyte 
stimulation i monkeys infected with dengue virus. They have also shown that replication of 
the virus occurs to a greater extent in cells previously exposed to DV than in normal cells 
(Marchette t aL 1976). In our previous tudy we noted that antibody plays a critical role in 
recovery from acute DV infection of immunosuppressed mice (Chaturvedi etal. 1977). In the 
present study we investigated the role of CMI, macrophages and antibody in the protection 
of mice against DV infection. 
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METHODS 
Mice. The study was carried out on male albino mice (Swiss strain) weighing 2o to 25 g 
(4 to 6 months old). 
Dengue virus (DV). Dengue type 2 virus (strain 23o85) was obtained from the Virus 
Research Centre, Poona and had undergone 12 adult mouse brain to brain passages in this 
laboratory. The strains produced IOO % mortality by the intracerebral (i.c.) route ill infant 
and adult mice. The virus used in the experiments was in the form of all infected adult 
mouse brain pool stored at -7o  °C. 
Titration ofD V. Localization of virus in different organs of adult mice, namely brain, heart, 
liver and spleen, were determined at different days after i.c. inoculation of DV. At autopsy, 
brain, liver, spleen and heart were removed. The organs were cut into thin slices and repeat- 
edly washed with ice-cold Hanks' balanced salt solution (HBSS) until the wash solution was 
free of blood. A IO% (w/v) organ suspension was prepared in chilled Eagle's minimum 
essential medium (MEM) containing antibiotics and lO% heat inactivated new-born calf 
serum. It was clarified by centrifugation i  the cold and serial Io-fold dilutions prepared in 
MEM were inoculated i.c. into groups of adult mice using doses of 0"03 ml. Mice were 
observed for 21 days and the LDs0 was calculated by the method of Reed & Muench (I938). 
Antibody titres. Individual mouse sera were assayed for haemagglutination inhibiting 
(HI) antibody by the technique of Clarke & Casals (I958) using 8 HA units of antigen and 
i-day-old chick red blood cells. The freeze-dried antigen of dengue type 2 virus (strain 
23o85) was obtained from the Virus Research Centre, Poona. 
Donor cells for adoptive immunization. Adult mice were given o'5 ml of a 2o % suspension 
of DV infected mouse brain by intraperitoneal (i.p.) inoculation. Three such doses were 
given at weekly intervals. At I, 2, 3, 4 and 5 weeks after the third dose, groups of mice were 
sacrificed. The spleen cells were teased out in MEM and the cell clumps were removed by 
aspiration. The cells were washed once and resuspended in MEM and counted in a haemo- 
cytometer. In different preparations the viable nucleated cells ranged from 90 to 94 % as 
assessed by the trypan blue dye exclusion test. 
Sensitized spleen cells were injected intravenously into normal mice at doses of I to 
4 x lO 8 cells. After 24 h they were challenged with varying doses of DV intracerebrally. 
Control groups received spleen cells from non-immune mice. 
Serum for adoptive immunization. From the group of mice used as donors of sensitized 
spleen cells for adoptive immunization, blood was collected directly from the heart at 
I, 2, 3, 4 and 5 weeks after the third dose of DV i.p. The blood was pooled from similarly 
treated mice and the serum was separated and stored at - 2o °C until used. The serum was 
diluted IO, ioo, 3oo and 5oo-fold and injected in doses of o'5 ml i.p. into normal mice 
followed 24 h later by IO 2 LD~o of DV i.c. 
Effect of adoptive cell transfer on antibody forming cells. To investigate the presence of 
suppressor cells in the immunized mice the following experiment was done. Mice of group A 
were given o. 5 ml of IO ~ LDs0 DV i.p. Mice of group B were given the same amount of DV i.p. 
followed 48 h later by the adoptive transfer of IO 8 immune spleen cells i.v. In mice of group 
C the DV given i.p. was followed 48 h later by adoptive transfer of IO s normal mouse spleen 
cells i.v. Mice from each group were sacrificed in batches of 4 to 5 daily for 9 days beginning 
24 h (in group A) or 72 h (in groups B and C) after infection. The spleens were collected and 
direct antibody forming cells against DV were counted by the technique of Jerne & Nordin 
(1963) as described elsewhere (Chaturvedi et al. I977; Tandon & Chaturvedi, I977). The 
immune spleen cells were obtained at various periods after immunization as described above 
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for adoptive transfer. The peak antibody forming cell response was observed after 6 or 7 
days and therefore, in another set of experiments, ensitized spleen cells obtained at 3 days 
and I to 5 weeks after immunization were transferred into normal mice as described above 
and the antibody forming cells were counted 6 and 7 days after DV was given i.p. 
Preparation of anti-thymocyte s rum (ATS). Antiserum against he thymocytes of Swiss 
mice was prepared in albino rabbits by the method of Levey & Medawar (I966) as described 
by Blanden 097o). Briefly, the rabbits were given two successive intravenous injections, I4 
days apart, of a single cell suspension of z × Io 8 viable thymocytes. The rabbits were bled 7
days after the second injection. Serum was separated, pooled and stored in small portions 
at - 7 ° °C after inactivation at 56 °C for 3o min. The cytotoxic titres against mouse thymo- 
cytes and spleen cells were determined in the presence of complement by the technique of 
Golub 097I)- The cytotoxicity was comparable to that of the anti-theta serum (prepared in 
mice immunized with thymocytes from young CzH/HeJ mice) obtained from Bionetics. 
Maryland, U.S.A. Treatment with these sera in the presence of complement killed 4I"5 °o 
of the spleen cells. 
Depletion of T-lymphocytes. The ATS was given in doses of o.I ml i.p. on alternate days 
from z days before the IO 2 LDs0 i.c. DV inoculation until the ~Ith day after inoculation 
(Camenga et al. I974). The control group was similarly treated with normal rabbit serum. 
Effect of cyclophosphamide. Mice were given cyclophosphamide (Endoxan-ASTA, 
Khandelwal Lab. Pvt. Ltd., ASTA-Werke, A-G, West Germany) in a single dose of 25o 
mg/kg body weight i.p. 24 h after ~o 2 LDs0 DV was given intracerebrally. 
Leucocyte migration inhibition test (LMI). This test was performed by the method of 
David et al. 0964) with spleen cells of mice given DV in various doses by different routes 
as follows. In mice of group A, o'o3 ml of Io z LDs0 of DV was inoculated i.c. and mice were 
sacrificed in batches of 5 at 24 h intervals from day I to ~o. Mice of group B were given 
o.I ml DV i.p. and group C received I ml of Io z LDs0 o fDV i.p. Mice of both these groups 
were sacrificed aily in batches of 4 to 5 from day I to 23 and then at 28 and 35 days. Mice 
of group D were given three i.p. doses of o'5 ml of 2o % DV infected mouse brain suspen- 
sion at weekly intervals and the mice were sacrificed I, z, 3, 4, 5 and 6 weeks after the last 
dose. 
There was almost no difference in the migration pattern whether live DV antigen or 
ultraviolet inactivated antigen was used. All the tests were set up in triplicate from each 
mouse. After incubation for about 24 h at 37 °C the migration pattern of the leucocytes was 
recorded on Whatman No. I chromatographic paper with the Camera Lucida, using a 
magnification of × I5. The area of migration was cut out and the paper was weighed. The °0 
migration inhibition was calculated according to David et al. (1964). An inhibition of 2o °~o 
or more was considered significant (Oritz-Oritz et al. I974). 
Effect of damage ofmacrophages. Failure to produce illness in mice by i.p. or i.v. inocula- 
tion of dengue virus, as observed in previous experiments, could be due to non-specific 
resistance by macrophages. Macrophages can be destroyed specifically by silica particles 
(Allison et al. 1966). Therefore, mice of groups A and B were given 5 ° mg of 2 #m sterilized 
silica particles (quartz dust) i.p.; mice of groups C and D were given 3 mg silica particles 
i.v. Mice of groups A and C were challenged with IO 2 LDs0 of DV i.p. or i.v. 2 h later. 
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RESULTS 
Distribution of DV in the body after i.c. inoculation 
Mice receiving DV intracerebrally remained apparently healthy for up to 4 days. On the 
5th or 6th day the fur became ruffled and the back arched. Later, mice became markedly 
sick and from the 8th day paralysis of the hind limbs set in. All the mice died between 8 and 
I2 days after inoculation. The distribution of the virus in different organs after intracerebral 
inoculation of ro 2 LDso DV is shown in Fig. t. The virus was found in the brain from the 
2nd day, reaching a peak on the 9th and Ioth day when the titres were IO 5"8 LDs0. The virus 
was detected from the 4th day in the liver, from the 5th day in the spleen and from the 7th 
day in the heart. 
Effect of adoptive immunization by sensitized spleen cells 
Adoptive immunization by sensitized spleen cells, obtained at different periods after 
immunization of mice, did not affect the outcome of DV infection (Table 0. Transfer of 
normal mouse spleen cells to control mice also had no effect. 
Effect of adoptive immunization by serum 
Adoptive transfer of serum, obtained at I or 2 weeks after immunization, protected a
smaller number of mice (Table 2). At later periods the protection was marked even with a
higher dilution of the serum. 
Effect of adoptive transfer of sensitized cells on antibody forming cells 
Adoptive transfer of immune spleen cells collected IO days after the immunization 
markedIy suppressed the antibody forming cells against DV in the spleen of recipient mice. 
The results summarized in Fig. 2 show that the maximum plaque forming cell (PFC) 
count in such mice was 285/2 × IO 6 spleen cells on the 7th day. In mice given normal spleen 
cells (group C) the peak count was 630 and in untreated controls it was 772 cells/2 x 1o 6 
spleen cells. 
Results of the second set of experiments where PFC were counted after i.v. transfer of 
immune spleen cells collected after 3 days, I, 2, 3, 4 and 5 weeks of immunization, are 
summarized in Table 3. The suppression of PFC continued to occur by transfer of immune 
cells up to 3 weeks after immunizing the donor, while at later periods the suppressive 
activity diminished. 
Leucocyte migration inhibition test 
Only the mice of group B (o.I ml DV i.p.) showed an inhibition of 20 + 1.8 % on day I4 
and the mice of group D (three doses of 0"5 ml of 2o% brain suspension i.p.) showed an 
inhibition of 2I + 2.8 % at 6 weeks. At every other period the migration inhibition was not 
significant with various doses of DV. 
Effect of treatment with ATS and cyclophosphamide 
The results summarized in Table 4 show that cyclophosphamide tr atment reduced the 
mean survival time but treatment with ATS did not potentiate the virus infection. The 
ATS treatment in vitro rendered 4I'5 % of spleen cells (T-lymphocytes) non-viable, showing 
the efficiency of the ATS preparation. 
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Fig. 1. Virus titres in different organs of infected mice on various days after intracerebral inocula- 
tion of DV. Each point represents the mean value for 5 mice for brain tissue and for 2 mice for the 
other organs. • • ,  Brain; • • ,  spleen; /~ &, liver; © (3, heart. 
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Tab le  I, Failure of adoptive immunization by spleen cells obtained from specifically immunized 
mice to protect against intracerebral infection by D V* 
Donor  cells Mortal ity 
No.  of  Median 
Period after cells'{" day of  
Source of cells immunizat ion × lO -8 DV LDs0~ D/T§  death 
Immune cells 1 week 2 lO 5 5/5 8.8 
2 10 3 4 /5  I I  
2 IO a 3 /5  lO"5 
2 weeks 4 1o 1 8/IO lO'8 
2 10 2 9/lO I I  
I IO 2 8 /10  8"6 
3 weeks 4 IO ~ 9/9  I 2.2 
2 IO 5 5 /5  12"2 
2 10 a 5/5 13"3 
2 IO ~ 3/5 13"7 
I lO 1 8/9 I2'0 
4 weeks 4 IO a 8/9 I 1.9 
2 tO s 8/9 11"6 
I 101 6 /8  9"2 
5 weeks 4 I o 1 6/8 I I" 2 
4 102 7/9  14"2 
Normal  cells - -  2 - -  0 /4  - -  
- -  4 io2 8/8 11'2 
- -  2 102 3 /4  9"6 
- -  1 IO~ 4 /5  9"2 
- -  4 I05 8/8 10"2 
- -  4 lol 7/ lO 14"1 
Without  ceils - -  - -  lO 5 IO/1O 8'4 
- -  - -  lO 8 16 /16  10'8 
- -  - -  101 9 / I I  I2" 5 
* Donor  spleen ceils for adoptive immunizat ion were obtained at weekly intervals after three i.p. weekly 
doses of o'5 ml of 2o% DV infected mouse brain suspension. The control group was given normal  mouse 
spleen cells, 
t Number  of  viable nucleated spleen cells given i.v, 24 h before DV was given i,c. 
LDs0 of  DV per o'o3 ml of  adult mouse brain given i.c. 
§ D /T  = Number  of  deaths/ tota l  number  tested. 
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Fig. 2. Antibody plaque forming cells (PFC) per z × IO 6 spleen cells of mice on different days after 
i.p. inoculation of DV. Each point represents he mean value, with standard error of the mean, from 
multiple slides from 4 to 5 mice. © (3, Mice given DV i.p.; • • ,  mice[given DV i.p. 
followed 48 h later by Io a normal mouse spleen cells i.v.; • • ,  mice given DV i.p. followed 
48 h later by IOs immune spleen ceils i.v. 
Effect of blockade of macrophages 
The results summarized in Table 5 show that selective destruction of macrophages by 
silica had no effect on the outcome of the infection. 
HI antibodies 
The HI antibody titre at I and 2 weeks after immunization was 20 to 4o while at 3, 4 and 
5 weeks, the titres ranged from I6O to 32o. Sera of some of the mice given sensitized spleen 
ceils i.v. showed antibody at a dilution of I : 2o. HI antibodies were also noted in low titres 
in groups of mice given a single dose ofDV i.p. or i.v. from the ioth or Iath day respectively. 
DISCUSSION 
Passive transfer of specific antiserum protected recipient mice against i.c. challenge with 
DV. Serum collected at early periods (I to 2 weeks) after immunization provided minimum 
protection while serum collected at later periods (3 to 5 weeks) protected a greater number 
of mice with a higher dilution of serum. Poor protection by sera collected early may well be 
due to the lower concentration of antibody. In our experiments here was evidence of sup- 
pression of antigen-specific antibody secretion as detected by Jerne's plaque technique after 
transfer of sensitized spleen cells. The suppressor activity diminished at 4 to 5 weeks (see 
Table 3) which may be responsible for the higher concentration f HI antibody at this period 
and consequently greater protection by the serum transfer. Such suppression by transfer of 
sensitized cells was not due to feedback suppression of antibody formation by effector 
T-cells as suggested by Pang & Blanden (1976) because cells obtained 4 to 5 weeks after 
immunization were not able to significantly suppress the antibody forming cells in the 
spleen of recipient mice (see Table 3). 
There are a number of host-arbovirus combinations in which virus replicates readily in 
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Tab le  2. Adoptive immunization by serum obtained from apecifically immunized mice 
protects against intracerebral challenge with D V 
Donor  serum Mortal ity 
Median 
Period after Serum day of % 
Source of  serum immunizat ion dilution D/T t  deaths survival 
Immune serum* i week I : IO 5 /6  12.2 I7 
I " IO0 5 /6  I3"4 17 
1:3oo 6/6 12"o o 
I "- 500 6/6  11" 5 O 
2 weeks I : IO 8/1o 13"2 20 
I : IOO 4 /6  IO.8 33 
I : 300 5/5  I 2"0 0 
1:500 5 /5  12"8 0 
3 weeks I : IO 0 /6  - -  IOO 
I " IOO I /4  16"O 75 
1:300  4/6  13"3 33 
1:500 5 /5  I4"0 O 
4 weeks t : IO I /5  14"7 80 
I : IOO I /5  18"o 80 
I : 3OO I /6  13"0 83 
I "500 4 /6  17'2 33 
5 weeks I :IO 3/6 14"7 66 
I : IOO 0/6  - -  IOO 
I : 3oo 2 /6  13"o 66 
1:500 6/6  14'o o 
Normal  mouse serum:~ - -  I : IO 6/6 I2"O o 
I " I00 6/6 12"2 0 
Virus control - -  6 /6  I I '3 o 
* Mice were immunized by three i.p. weekly doses of DV. Blood was collected at weekly intervals after'the 
third dose and 0"5 ml of  the serum dilution was injected i.p. into normal  mice, followed 24 h later [by 
lO 3 LDs0 of DV i.c. 
I" D /T  = Number  of  deaths/tota l  number  tested. 
In  control mice, normal  mouse serum was injected. 
Tab le  3. Suppression of antibody forming cells against D V in the spleen by adoptive transfer 
of sensitized spleen cells 
Donor  cells* 
after 
immunizat ion AFCt  (after DV challenge) 
at different , -~  
periods 6th day 7th day 
3 days 228 + 52 283 + 25 
I week 236 _ 27 322 + 47 
2 weeks 297 ___ 54 324 _ 50 
3 weeks 322 + 62 330 _ 30 
4 weeks 47I _ 25 634 +_ 84 
5 weeks 520 + 50 757 + 175 
* Sensitized spleen cells obtained at different periods f rom mice given three doses of  DV i.p. at weekly 
intervals, were transferred intravenously into recipient mice who were given DV i.p. 48 h earlier. 
t Ant ibody forming ceils (AFC) against DV were counted in the spleen of  recipient mice on the 6th and 
7th days after DV inoculation. Each value (the mean of triplicate tests on 4 to 5 mice + s.d.) is expressed as 
AFC per 2 x io ~ spleen cells. 
2o v iR  39 
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Table 4. Potentiation of DV infection by cyclophosphamide but not by anti-thymocyte s rum 
Mortality 
c 
Median 
day of 
Virus Treatment* D/Tt  death 
DV - -  2o / zo m. z 
DV ATS 17/2o 12"2 
- -  ATS o/to - -  
DV NRS 1o/lo I 1 "2 
DV CY I5/I 5 6.6 
- -  C Y  O/ IO  - -  
* DV (I0 ~ LDs0) was injected intracerebrally and o.t ml antithymocyte s rum (ATS) or normal rabbit 
serum (NRS) was given i.p. every other day from a days before infection to I2 days after infection. Cyclo- 
phosphamide (CY) was given in doses of 25o mg/kg ~ day after DV infection. 
t D/T = Number of deaths/total number tested. 
Table 5- Failure of pre-treatment with silica to potentiate D V infection by peripheral routes* 
DV challenge Mortality 
Group Treatment with lO 2 LDso (D/Tt) 
A 50 mg silica i.p. DV i.p. O/I2 
B 50 mg silica i.p. - -  o/Io 
C 3 mg silica i.v. DV i.v. o/Io 
D 3 mg silica i.v. - -  0/8 
E - -  DV i.p. O/12 
F - -  DV i.v. o/15 
G - -  DV i.c. IO/I0 
* Mice were pre-treated intravenously or intraperitoneally with 2 #m sterile silica particles suspended in 
Hank's balanced salt solution to destroy the macrophages. DV was inoculated at to sLD~ 0 by the same route 
2 h later. The control mice were given either silica or virus alone. 
t D/T = Number of deaths/totaI number tested, 
brain but relatively poor ly  in peripheral  tissues (Albrecht, 1968; Cole & Wisseman, 1969). In 
the present study and in an earlier study (Chaturvedi et al. J974) high DV titres were noted 
in the brain tissue while liver, heart and spleen had low titres. Repl icat ion of  DV associated 
with changes in enzymes and metabol ites also occurs in skeletal muscles (Agrawal et al. 
I978) and in liver and brain tissues (unpubl ished ata) in mice. When inoculated by the 
intraperitoneal route, dengue virus fails to kill adult  mice even with very large doses (Nathan-  
son & Cole, I97O). 
Out of  four groups of  mice sensitized wilh DV given in various doses by different routes, 
a significant LMI  was noted only on two occasions, to the extent of 20 + 1.8 and 2I +__ 2.8%. 
This is in contrast o the higher values of  6o to 65 % LMI  observed in Coxsackie B4 virus 
infected mice with specific antigen (Chaturvedi et al. I978). Stimulation of  peripheral b lood 
lymphocyte in DV infected monkeys have been noted in some experiments by Halstead 
et al. (1973). 
Poor  cel l-mediated inlmunity in DV infection may be due to suppressor cell activity or to 
selective destruction of  T-cells. This was shown to occur both in the circulation and in the 
thymus dependent areas of lymph nodes and spleen in dengue virus infection (Bhamara- 
pravati  et al. I967; Aung Khin et al. I975). 
Our results do not appear to demonstrate a role for cel l -mediated control  o f  DV infection 
in mice. There are three observations that support  his assumption:  (a) failure of  adoptively 
transferred sensitized spleen cells to protect mice against challenge with a small dose 
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0o  LDs0) of DV; (b) failure of anti-thymocyte serum treatment of mice to potentiate DV 
infection; and (c) failure of adoptive transfer or reconstitution of immunosuppressed mice 
by sensitized spleen cells to protect against DV (Chaturvedi et al. I977). Adoptive transfer 
of sensitized spleen cells could have provided protection by B-cells through elaboration of 
antibody as observed with Coxsackie B 4 virus (Chaturvedi et al. ~978). However, in the 
present experiments antibody against DV was detected only in low titres (1:2o) in the sera of 
recipient mice on the 8th and 9th days after transfer of sensitized spleen cells. Such low 
titres of antibody were not sufficient o protect them against DV challenge. 
We could not produce morbidity in mice after DV infection by i.p. or i.v. routes even 
after giving silica. If the resistance of mice to i.p. or i.v. infection with DV was due to 
macrophages then selective destruction of macrophages by silica should have caused 
increased susceptibility as noted in herpes simplex (Hirsch et al. I97o), yellow fever 
(Zisman et al. I97 I) and Coxsackie B3 virus (Rager-Zisman & Allison, I973) infections. 
Therefore, macrophages do not appear to have a significant role in protection against DV. 
Our findings support the view of Van der Groen et al. (I977) that macrophages are not 
necessarily absolute barriers in arbovirus infections. 
The findings of the present study substantiate our results reported elsewhere (Chaturvedi 
et al. I977) that humoral antibody plays a critical role in recovery from acute dengue virus 
infection in mice whereas macrophages and cell-mediated immunity appear to have no 
protective role. 
We are grateful to Dr R. M. L. Mehrotra for constant encouragement. We thank Shri 
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